<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="epidemics of severe acute respiratory syndrome (SARS) in 2003 and" exact="Middle East respiratory syndrome" post="(MERS)5 in 2012, but to date there are no"/>
 <result pre="infected i.p. with EVâ€�A71â€�MZâ€�MA1. AZM dose 30â€‰mg/kg/day Zeng et al13" exact="Ebola" post="(Ebola viruses) AZM demonstrates high in vitro antiâ€�viral potency"/>
 <result pre="severe ARDS, using a propensity score analysis Kawamura et al15" exact="Influenza" post="A (Orthomyxovirus) Reduction in ILâ€�6, ILâ€�8, ILâ€�17, CXCL9, sTNF"/>
 <result pre="levels of phosphorylated TBK1 and IRF3. 2.4 Antiâ€�viral effects in" exact="Ebola" post="AZM was similarly evaluated in a drug screen for"/>
 <result pre="DeebAM, Alâ€�HameedF, et al. Macrolides in critically ill patients with" exact="Middle East respiratory syndrome." post="Int J Infect Dis. 2019;81:184â€�190.30690213 6collab: Câ€�CRCEa . Global"/>
 <result pre="Antimicrob Agents. 2019;53(4):362â€�369.30599241 14MadridPB, PanchalRG, WarrenTK, et al. Evaluation of" exact="Ebola" post="virus inhibitors for drug repurposing. ACS Infect Dis. 2015;1(7):317â€�326.27622822"/>
 <result pre="HasegawaS, SriwilaijaroenN, et al. Clarithromycin inhibits progeny virus production from" exact="human influenza" post="virusâ€�infected host cells. Biol Pharm Bull. 2008;31(2):217â€�222.18239276 42YamayaM, ShinyaK,"/>
 <result pre="or without concomitant azithromycin among hospitalized patients testing positive for" exact="coronavirus disease 2019" post="(COVIDâ€�19). JAMA Cardiol. 2020;e201834. doi:10.1001/jamacardio.2020.1834. 56MaisonnasseP, GuedjJ, ContrerasV, et"/>
</results>
